# Lopinavir and Ritonavir

NDC: 42385-933
Generic name: Lopinavir and Ritonavir
Labeler / Manufacturer: Laurus Labs Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20220322

FDA application: ANDA213857

## Active ingredients

- LOPINAVIR: 100 mg/1
- RITONAVIR: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42385-933"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42385-933
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7072c60-6dbf-4125-95e7-497c05a9e6a6